Composition of Other Balance Sheet Items (Tables)

9 Months Ended

Sep. 30, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of inventories

Inventories

	September 30, 2023		December 31, 2022
	(unaudited)
Raw materials	$	21,556	$	24,820
Work in process	26,966		31,710
Finished goods	34,958		35,011
Total	$	83,480	$	91,541

Schedule of property and equipment

Property and Equipment

	September 30, 2023		December 31, 2022
	(unaudited)
Lab equipment and furniture	$	12,620	$	12,127
Leasehold improvements	14,023		14,023
Software	883		883
Computer equipment	1,078		983
Construction-in-progress	—		206
	28,604		28,222
Less accumulated depreciation and amortization	(14,916)		(13,049)
Property and equipment, net	$	13,688	$	15,173

Schedule of accrued expenses and other current liabilities

Accounts Payable and Accrued Liabilities

	September 30, 2023		December 31, 2022
	(unaudited)
Accounts payable	$	3,389	$	10,543
Accrued compensation, benefits, & related accruals	19,025		16,963
Accrued sales & marketing	11,656		16,783
Accrued R&D expenses	9,659		7,490
Accrued manufacturing expenses	9,569		15,216
Accrued royalties (1)	8,852		12,022
Operating lease liabilities, current portion (2)	8,480		6,791
Other accrued expenses	7,841		10,534
Total	$	78,471	$	96,342

_______________________________

(1) Refer to Note 15, Commitments and Contingencies.

(2) Refer to Note 12, Leases.

Schedule of accrued product returns and rebates

Accrued Product Returns and Rebates

	September 30, 2023		December 31, 2022
	(unaudited)
Accrued product rebates	$	108,129	$	106,657
Accrued product returns	54,344		45,008
Total	$	162,473	$	151,665